ECM2026, 14-17 June 2026, Copenhagen, DenmarkWelcome to ECM2026
This year’s conference will feature an inspiring line-up of plenary sessions and focused breakout sessions exploring new research in extracellular matrix biology and fibrosis.
Download the tentative programTentative sessions
To read more about this year’s session please click here
Pleanary sessions
- Intestines and the ECM: a target to treat?
- Fibroblasts vs cancer cells – who is in control?
- Tissue destruction in autoimmunity and chronic inflammation
- Dermatology- a sign of a systemic disease
- Drivers of multi-organ fibrosis
- The epithelium as a barrier: IPF & COPD
- ECM in health and disease
Break out-sessions
- Translational ECM Research
- Fibroaging
- Degradomics and proteomics
- Fibrogenesis as a unifying mechanism underlying multiorgan diseases
- ECM biomarkers
- The role of B-cells in inflammation regression
- ECM pharmacology: Liver disease
- ECM Pharmacology: Lung diseases
- Cancer biology and the ECM
- Fibroblasts heterogeneity
